Americafirst Capital Management’s Gilead Sciences GILD Stock Holding History

Americafirst Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$658K	Buy	+8,125	New	+$621K	0.89%	32
2016 Q4	–	Sell	-4,373	Closed	-$346K	–	215
2016 Q3	$346K	Sell	4,373 -19,388	-82%	-$1.57M	0.29%	93
2016 Q2	$1.98M	Sell	23,761 -207	-0.9%	-$18.4K	1.28%	25
2016 Q1	$2.2M	Buy	23,968 +13,604	+131%	+$1.23M	1.38%	9
2015 Q4	$1.05B	Buy	10,364 +2,997	+41%	+$312K	0.64%	56
2015 Q3	$723M	Sell	7,367 -2,857	-28%	-$317K	0.43%	89
2015 Q2	$1.2M	Buy	+10,224	New	+$1.12M	0.65%	50
2015 Q1	–	Sell	-12,694	Closed	-$1.2B	–	292
2014 Q4	$1.2B	Buy	+12,694	New	+$1.31M	0.58%	57

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Americafirst Capital Management's GILD Position: Q3 2017 in Review

Americafirst Capital Management opened a new position in Gilead Sciences (GILD) in Q3 2017: 8,125 shares worth $658K. The stake represents 0.89% of the portfolio and ranks #32 among its holdings. This is a return to the name: Americafirst Capital Management previously reported a position in GILD as recently as Q3 2016.

Americafirst Capital Management first reported a position in GILD in Q4 2014 and has held it in 8 quarters since. The position peaked at $1.2B in Q4 2014. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

Americafirst Capital Management held 8,125 shares of Gilead Sciences worth $658K as of Q3 2017.
Gilead Sciences was a new Americafirst Capital Management position in Q3 2017.
Gilead Sciences made up 0.89% of Americafirst Capital Management's portfolio in Q3 2017, its #32 holding.
Americafirst Capital Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 8 quarters since.
Americafirst Capital Management's Gilead Sciences position peaked at $1.2B in Q4 2014.
1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Americafirst Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.